S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
ETFs
UK
LSE
Ls 2x Salesforc (CRME)
Ls 2x Salesforc (CRME) News

CRME

Ls 2x Salesforc (CRME)

Ls 2x Salesforc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:LSE:CRME

1 2 3 4 Next >>

Date	Time	Source	Headline	Symbol	Company
25/04/2023	00:47	UK Regulatory	Leverage Shares PLC Issuer Call Redemption Confirmation	LSE:CRME	Ls 2x Salesforc
22/12/2009	09:05	PR Newswire (US)	Cardiome Pharma Corp. Permitting Automatic Securities Disposition and Purchase Plans	LSE:CRME
18/12/2009	10:00	PR Newswire (US)	Cardiome Announces Investigational Candidate, Vernakalant, Meets Primary Endpoint in European Comparator Study	LSE:CRME
10/11/2009	00:40	PR Newswire (US)	Cardiome Reports Third Quarter Results	LSE:CRME
07/11/2009	10:00	PR Newswire (US)	Cardiome to Release Third Quarter Results	LSE:CRME
03/11/2009	06:35	PR Newswire (US)	Cardiome To Present At Oppenheimer Healthcare Conference	LSE:CRME
29/10/2009	07:58	PR Newswire (US)	Cardiome And Astellas Announce Initiation Of Patient Enrolment In ACT 5 Trial	LSE:CRME
17/10/2009	11:54	PR Newswire (US)	Cardiome Pharma Corp. Announces Final Results of Tender Offer	LSE:CRME
14/10/2009	21:00	PR Newswire (US)	Cardiome Pharma Corp. Announces Preliminary Results of Tender Offer	LSE:CRME
02/09/2009	04:57	PR Newswire (US)	Cardiome Pharma Corp. Announces Commencement of US$27.5 Million Tender Offer	LSE:CRME
29/08/2009	03:30	PR Newswire (US)	Cardiome Announces Upcoming Presentation Of Results Of Phase 2b Clinical Trial Of Vernakalant (Oral) At The European Society Of	LSE:CRME
26/08/2009	07:11	PR Newswire (US)	Cardiome Pharma Corp. Announces Tender Offer To Purchase Up To US$27.5 Million Of Its Common Shares	LSE:CRME
11/08/2009	21:45	PR Newswire (US)	Cardiome Reports Second Quarter Results	LSE:CRME
11/08/2009	09:45	PR Newswire (US)	Additional Clinical Trial to be Conducted for KYNAPID Under FDA Special Protocol Agreement	LSE:CRME
11/08/2009	06:35	PR Newswire (US)	Cardiome to Hold Conference Call	LSE:CRME
04/08/2009	07:16	PR Newswire (US)	Cardiome Announces Management Transition	LSE:CRME
29/07/2009	01:45	PR Newswire (US)	Cardiome Achieves Milestone From Collaboration With Merck Co., Inc.	LSE:CRME
19/05/2009	22:30	PR Newswire (US)	Cardiome Announces That Collaboration and License Agreement with Merck & Co., Inc. Now Effective	LSE:CRME
16/05/2009	06:05	PR Newswire (US)	Cardiome Reports First Quarter Results	LSE:CRME
09/04/2009	08:13	PR Newswire (US)	Cardiome to Hold Conference Call	LSE:CRME
29/11/2008	09:31	PR Newswire (US)	Cardiome Discloses Chairman And CEO's Involuntary Share Sale	LSE:CRME
15/11/2008	10:40	PR Newswire (US)	Cardiome Reports Third Quarter Results	LSE:CRME
24/10/2008	13:40	PR Newswire (US)	Cardiome Announces Filing Of Shelf Registration Statement	LSE:CRME
10/10/2008	03:20	PR Newswire (US)	Cardiome Provides Regulatory Update	LSE:CRME
13/08/2008	06:05	PR Newswire (US)	Cardiome Reports Second Quarter Results	LSE:CRME
12/08/2008	06:30	PR Newswire (US)	Cardiome to Release Second Quarter Results and Hold Conference Call	LSE:CRME
11/08/2008	23:18	PR Newswire (US)	Cardiome And Astellas Announce Receipt Of FDA Approvable Letter For KYNAPID(TM)	LSE:CRME
24/07/2008	04:10	PR Newswire (US)	Cardiome Announces Preferred Share Financing	LSE:CRME
14/07/2008	22:25	PR Newswire (US)	Cardiome Announces Positive Phase 2b Results For Oral Vernakalant	LSE:CRME
14/07/2008	02:00	PR Newswire (US)	Cardiome To Hold Conference Call	LSE:CRME

Showing the most relevant articles for your search:LSE:CRME

1 2 3 4 Next >>

DF Deutsche Forfait

Biloxi Marsh Lands (CE)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions